Please use this identifier to cite or link to this item:
http://ri.uaemex.mx/handle20.500.11799/109382
DC Field | Value | Language |
---|---|---|
dc.creator | Arturo González Santana | - |
dc.creator | YESICA MARIA RODRIGUEZ CORTES | - |
dc.creator | Leicy jazmín Ruiz Barrera | - |
dc.creator | ARACELI CONSUELO HINOJOSA JUAREZ | - |
dc.creator | Joel Alberto Vargas Hernández | - |
dc.creator | Deisy Julieth Abril Riaño | - |
dc.creator | Hugo Mendieta Zerón | - |
dc.date | 2020-11-02 | - |
dc.date.accessioned | 2022-04-21T06:02:53Z | - |
dc.date.available | 2022-04-21T06:02:53Z | - |
dc.identifier | http://hdl.handle.net/20.500.11799/109382 | - |
dc.identifier.uri | http://ri.uaemex.mx/handle20.500.11799/109382 | - |
dc.description | Objectives: Pancreatic duodenal homeobox factor-1 (PDX-1) and neurogenin-3 (NGN-3) are progenitor cell markers in the pancreas. The aim was to compare their serum levels in women with and without gestational diabetes mellitus (GDM). Material and Methods: This prospective, cross-sectional study included two groups: (a) Women with normal gestation and (b) with GDM. PDX-1 and NGN-3 serum expression was determined by qRT-PCR. Student’s t-test or the Mann–Whitney U-test was used to contrast both groups and the Pearson or Spearman correlation was used. A multiple regression was done introducing body mass index and the relative expression of both genes as independent variables and glucose as dependent variable. Statistical significance was tested at P ≤ 0.05 level. Results: Thirty-eight patients (mean age was of 29.00 ± 7.74 years) were included, 22 belonged to the normal pregnancies, and 16 to GDM. Using the ΔΔCt method, the expression fold change for PDX-1 was 0.458 and for NGN-3 it was 0.361. There was a significant positive correlation between the expressions of both genes. The multiple regression was significant for both genes expression and glucose levels in case of having normal weight. Conclusion: PDX-1 and NGN-3 low serum expression could be predictors of higher glucose levels in normal pregnancies | - |
dc.language | eng | - |
dc.publisher | Global Journal of Medical, Pharmaceutical, and Biomedical Update | - |
dc.relation | 15 | - |
dc.relation | 6 | - |
dc.relation | 10.25259/GJMPBU_19_2020 | - |
dc.rights | info:eu-repo/semantics/openAccess | - |
dc.rights | http://creativecommons.org/licenses/by-nc-nd/4.0 | - |
dc.source | 1694-0423 | - |
dc.subject | PDX-1 | - |
dc.subject | NGN-3 | - |
dc.subject | Gestational Diabetes | - |
dc.subject | info:eu-repo/classification/cti/3 | - |
dc.title | Pancreatic Duodenal Homeobox Factor-1 and Neurogenin-3 Serum Expression in Gestational Diabetes | - |
dc.type | article | - |
dc.audience | students | - |
dc.audience | researchers | - |
item.grantfulltext | none | - |
item.fulltext | No Fulltext | - |
Appears in Collections: | Producción |
Google ScholarTM
Check
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.